24 /100
LOW RISK
Score updated Jul 13, 2026

MYPS — PLAYSTUDIOS, Inc. Dilution Risk Tracker

Track MYPS dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track MYPS — Get alerts when the score changes →

As of July 13, 2026, PLAYSTUDIOS, Inc. (MYPS) has a DilutionWatch DilutionScore of 24/100, rated LOW dilution risk. PLAYSTUDIOS, Inc. has a market capitalization of $71.35M, 125.75M shares outstanding, 101 institutional holders tracked. Key dilution vectors include approximately 999 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

📊 Score Breakdown

📋 Offering Ability
39
💰 Cash Runway
0
📊 Float Risk
17
⚠️ Warrant Exposure
40
🔄Convertible Debt

🌦️ Dilution Forecast

🌥️
Advisory
Moderate dilution signals present
27%
🔄 Reverse Split 55%
• 50-day avg $0.46 below $1 exchange minimum
🔔 Track MYPS — Get forecast alerts →

💹 Market Data

Market Cap$71.35M
Shares Outstanding125.75M
Float91.06M
Cash$103.68M
Debt$6.91M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 19.1% shares (2026Q1 vs prior)
101 institutional holders · 48.27M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 7.64M shares
#2 BlackRock, Inc. 6.89M shares
#3 Almitas Capital LLC 4.70M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest146.7K
Days to Cover1.0
% of Float0.2%
FINRA data as of Jun 30, 2026

📁 Recent SEC Activity

xbrl XBRL WARRANT Dec 31, 2025
Full SEC filing analysis available with free account

📰 Recent News

No recent news

📋 What This Means for MYPS Shareholders

PLAYSTUDIOS, Inc. (MYPS) has a DilutionScore of 24/100, rated Low dilution risk. At this score level, DilutionWatch's real-time EDGAR monitoring shows limited near-term dilution signals. This does not mean zero dilution risk — shelf registrations can be filed and activated quickly — but the current filing profile shows no major outstanding dilution programs. Score as of July 13, 2026.

DilutionWatch's EDGAR monitoring for MYPS shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.

DilutionWatch tracks over 25 SEC filing types for MYPS in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for MYPS alongside comparable low-risk stocks. Not financial advice — this analysis is for informational purposes only.

Track MYPS Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking MYPS — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

🔗 Related Stocks — LOW Risk

Other LOW dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
🔬 More Research for MYPS
📊 MYPS FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 MYPS Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.